Natus medical inc (BABY)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Interest Paid, Excluding Capitalized Interest, Operating Activities

3,870

4,580

5,470

6,274

6,034

6,169

5,834

5,328

4,966

4,464

3,056

2,133

1,011

41

41

10

8

0

70

125

250

434

591

674

884

1,311

1,358

1,414

1,090

489

235

66

78

114

0

0

0

Operating activities:
Net loss

11,130

-15,671

-28,986

-43,021

-50,185

-22,935

-18,396

-21,334

-23,789

-20,293

-2,965

18,858

34,404

42,594

40,905

38,527

37,865

37,924

39,819

36,709

34,320

32,478

31,437

29,901

26,460

23,147

18,706

10,672

6,976

3,823

-17,931

-16,031

-13,994

-11,179

0

0

0

Adjustments to reconcile net loss to net cash provided by operating activities:
Excess tax benefit on the exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,104

8,983

9,150

6,385

7,525

6,318

5,452

5,222

3,109

131

634

-193

-381

0

0

0

-

0

0

0

Provision for losses on accounts receivable

1,351

1,584

2,532

3,780

7,788

6,909

7,184

7,034

9,216

10,017

8,887

7,435

2,490

1,123

1,491

1,673

1,572

1,496

1,375

1,476

802

991

392

143

370

277

1,570

1,205

1,437

1,319

-1,228

-393

-99

-358

0

0

0

Loss on commencement of sales-type leases

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

30,005

30,722

31,157

32,596

33,659

33,863

34,891

32,973

31,269

30,098

24,918

22,302

19,400

16,879

17,461

17,205

17,227

15,987

14,538

13,311

11,440

11,759

11,861

12,161

13,017

12,848

12,813

13,064

12,902

12,615

12,777

11,562

10,488

10,192

0

0

0

Loss on disposal of property and equipment

-312

-449

-818

-1,068

-873

-746

-375

-145

-26

21

-6

4

39

29

26

36

-10

5

0

0

0

-

-

-

-

0

-475

-429

-418

-414

-160

-106

-264

-267

0

0

0

Warranty reserve

3,236

2,886

4,683

2,870

3,647

2,168

136

637

1,439

5,370

4,968

6,330

4,811

2,934

9,231

9,888

10,782

10,729

5,657

4,864

2,792

2,306

2,540

1,762

1,672

1,938

1,730

1,812

1,892

1,452

-2,153

-2,175

-1,821

-1,468

0

0

0

Share-based compensation

8,089

8,352

7,982

15,881

17,243

17,051

17,668

10,102

9,051

9,445

9,274

8,980

8,863

9,008

8,528

8,465

8,123

6,953

6,740

6,376

6,184

6,062

6,174

6,076

6,327

6,078

6,021

7,063

6,623

6,420

6,447

5,887

6,101

6,468

0

0

0

Impairment charge for sale of entity

0

24,571

24,571

24,571

24,571

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

-10,029

-9,817

-9,136

-11,907

-11,401

5,199

13,858

19,511

30,349

30,473

13,236

-3,231

-7,091

-19,723

-10,708

6,711

5,419

15,272

10,362

7,278

2,726

2,431

-3,502

-8,663

-10,852

-9,357

2,099

13,566

21,019

22,031

21,100

4,770

4,619

-160

0

0

0

Inventories

-8,218

-7,185

4,334

7,435

14,804

7,443

4,393

994

-5,844

-7,581

-5,476

1,928

2,143

7,668

11,571

7,000

11,892

12,232

8,105

9,250

4,186

2,017

2,177

-122

1,817

2,679

1,323

1,827

-1,370

-5,259

-9,767

-14,028

-10,888

-3,741

0

0

0

Prepaid expenses and other assets

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

Accounts payable

8,107

-1,367

9,511

952

1,291

4,105

4,346

-953

-859

-1,385

-8,433

-1,075

-2,323

-4,965

-6,029

450

-1,599

3,270

-1,787

-5,504

-3,859

-7,648

1,869

1,076

-795

-1,387

-3,770

5,322

8,327

11,311

10,201

-2,785

-4,270

-7,062

0

0

0

Accrued liabilities

-12,020

-4,010

-2,422

-8,561

-7,165

-2,527

14,926

19,339

16,999

5,421

-9,016

-13,447

-11,538

-6,967

-9,069

-3,199

-7,373

-6,177

8,850

4,506

6,864

6,595

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

3,600

3,392

2,702

3,128

2,744

2,076

2,403

3,343

3,411

-7,232

-19,005

4,868

4,104

13,879

25,925

224

-831

-1,118

-1,798

-682

98

-775

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Deferred income tax

5,244

5,364

17,048

13,996

13,818

13,714

12,221

1,391

-3,127

-4,032

-14,290

-3,375

1,553

2,437

3,974

3,213

58

-1,543

-3,819

-5,610

-3,105

-3,240

-7,660

-4,810

-3,651

-1,503

9,379

8,751

8,600

8,210

2,663

2,568

2,774

3,006

0

0

0

Accrued liabilities and deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

Net cash provided by operating activities

70,929

60,060

61,977

45,741

33,188

33,020

24,434

20,738

24,775

19,726

18,433

50,008

54,581

72,687

70,426

50,322

42,422

36,852

43,886

42,523

50,271

42,143

49,267

51,266

43,416

36,797

23,069

9,984

12,327

19,392

23,141

29,896

25,460

22,752

0

0

0

Investing activities:
Acquisition of businesses, net of cash acquired

-

-

-

-

-

-

-

-

-

190,888

142,592

157,135

151,905

15,849

18,574

8,875

7,855

14,284

11,559

11,559

12,078

4,925

4,925

4,925

4,925

18,600

0

0

0

-

-

-

-

-

-

-

-

Purchase of property and equipment

6,440

5,326

6,620

7,407

7,863

7,875

6,444

5,989

5,568

4,066

3,759

2,547

2,236

3,186

3,254

3,796

4,590

4,068

3,493

4,415

4,832

4,239

4,964

2,510

1,944

1,825

-956

1,463

1,715

2,246

5,786

4,895

4,524

4,180

0

0

0

Acquisition of intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,126

1,675

1,795

1,446

1,481

1,024

1,683

1,241

1,875

0

0

0

-

-

-

-

-

-

-

-

Sale of intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Sales of short-term investments

-

-

-

-

-

-

-

-

-

34,019

34,019

34,019

24,935

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,005

0

0

0

Net cash used in investing activities

-6,453

-5,339

-6,661

-7,787

-8,377

-8,389

-55,226

-49,588

-45,667

-160,935

-120,922

-159,651

-163,437

-53,264

-47,435

-13,148

-13,569

-19,478

-16,727

-17,769

-18,356

-10,645

-10,913

-9,118

-8,110

-22,300

-22,044

-23,117

-81,201

-62,463

-64,520

-79,023

-20,721

-19,372

0

0

0

Financing activities:
Proceeds from stock option exercises and Employee Stock Purchase Program purchases

3,367

3,635

3,126

8,030

11,139

11,448

11,734

6,485

3,795

3,466

3,327

3,496

3,255

3,630

6,722

6,750

9,562

10,258

11,781

12,471

11,229

16,210

14,399

14,588

13,166

8,981

5,984

4,934

3,842

1,857

1,421

1,691

2,123

2,319

0

0

0

Excess tax benefit on the exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,104

8,983

9,150

6,385

7,525

6,318

5,452

5,222

3,109

131

634

-193

-381

-334

-1,068

-342

-160

0

0

0

Repurchase of common stock

10,495

0

1

0

894

5,630

5,629

5,630

5,696

2,268

3,300

4,803

11,534

19,289

20,430

22,764

19,276

11,525

10,578

8,940

5,945

4,633

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Taxes paid related to net share settlement of equity awards

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Principal payments of financing lease liability

446

478

404

265

165

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from borrowings

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of contingent consideration related to a business combination

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent consideration earn-out

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from short-term borrowings

-

-

-

-

-

-

-

-

-

-

60,000

10,000

20,000

16,000

16,000

16,000

6,000

0

0

0

0

-

-

-

-

-

-

-

0

-

-

-

-

2,553

0

0

0

Deferred debt issuance costs

-

-

-

-

-

-

-

-

-

354

354

571

571

533

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on borrowings

60,000

50,000

45,000

40,000

30,000

50,000

40,000

40,000

70,000

45,000

45,000

50,000

10,000

16,000

16,000

6,000

6,000

0

8,000

16,409

32,938

38,017

40,061

36,248

55,163

52,226

44,311

41,852

6,461

4,359

3,124

2,000

3,004

3,013

0

0

0

Net cash provided by (used in) financing activities

-9,579

-48,532

-43,885

-38,665

-26,651

-49,512

-42,602

5,684

-27,804

5,826

147,872

90,954

134,463

118,417

-17,700

-9,832

-11,510

832

-2,820

-8,040

-23,728

-20,914

-24,711

-15,333

-1,392

17,247

23,187

24,316

55,488

33,417

30,263

30,192

156

1,699

0

0

0

Exchange rate changes effect on cash and cash equivalents

-1,304

735

-2,809

-2,188

-9,208

-7,696

-4,571

-2,229

9,389

10,782

5,949

2,708

-3,114

-6,758

-6,419

-4,296

-3,057

-2,295

56

506

-777

-132

-29

293

1,321

1,305

480

770

324

-105

-160

-1,854

-1,378

-646

0

0

0

Net increase (decrease) in cash and cash equivalents

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

-

-

-

-

-

-32,577

-77,965

-25,395

-39,307

-124,601

51,332

-15,981

22,493

131,082

-1,128

23,046

14,286

15,911

24,395

17,220

7,410

10,452

13,614

27,108

35,235

33,049

24,692

11,953

-13,062

-9,759

-11,276

-20,789

3,517

4,433

0

0

0

Supplemental disclosure of cash flow information:
Cash paid for income taxes

8,713

6,445

5,470

7,341

8,814

9,247

9,374

9,918

7,111

5,740

12,632

11,645

12,680

16,344

12,840

15,428

13,965

10,164

6,283

4,208

5,247

5,672

7,784

9,336

9,268

12,908

11,796

11,604

9,724

6,942

4,973

3,481

3,111

1,878

0

0

0

Non-cash investing activities:
Property and equipment included in accounts payable

59

69

100

109

-41

167

173

-56

267

148

32

367

138

134

248

144

343

289

48

144

29

122

275

-1

84

80

0

0

0

-

-

-

-

-

-

-

-

Inventory transferred to property and equipment

353

300

662

1,507

1,193

1,211

825

526

922

1,006

998

1,714

1,339

1,303

1,499

825

888

1,056

1,393

1,433

1,329

1,350

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Transfer of leased assets to sales-type leases

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-